Bimekizumab Versus Ustekinumab in Plaque Psoriasis: Lasting Efficacy Translates to Rapid and Sustained Improvements in Quality of Life in the BE VIVID Multicenter, Randomized, Double-Blinded Phase 3 Trial

Saved in:
Bibliographic Details
Published inSkin (Milwood, N.Y.) Vol. 5; no. 1; p. s17
Main Authors Gordon, K, Foley, P, Rich, P, Duffin, K, Pinter, A, Griffiths, CEM, Wang, M, Vanvoorden, V, Staelens, F, Ciaravino, V, Merola, JF
Format Journal Article
LanguageEnglish
Published 01.01.2021
Online AccessGet full text

Cover

More Information
ISSN:2574-1624
2574-1624
DOI:10.25251/skin.5.supp.17